Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Study of Carfilzomib Administered Once Weekly in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

NCT02335983 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02335983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02335983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Study of Carfilzomib Administered Once Weekly in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
Lead sponsor
Amgen
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2015
Completion date
October 28, 2019
Enrollment
107 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma